NCT07581002 · Interventional trial
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Overall registry status Recruiting
Phase 2 · Phase 3
Conditions Acute Myeloid Leukemia
Delaware Valley sites
- Penn Medicine University of Pennsylvania Health System /ID# 279382 · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory